Logo

Tempus

In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More

News items for the week of Nov 8, 2021.

Cedars-Sinai, Tempus Partner on Molecular Database Initiative

The partners launched the Molecular Twin initiative to collect cancer patients' DNA, RNA, and protein information and use it to inform treatment and advance research.

Tempus Submits PMA Application for Tumor Profiling Assay to FDA

The firm has submitted companion diagnostic and tumor profiling, and MSI status claims using DNA from FFPE tumor tissue and matched normal specimens.

Rain Therapeutics, Tempus Partner to Identify Patients with MDM2-Amplified Tumors for Basket Trial

Tempus will provide centralized DNA and RNA tumor sequencing to help Rain enroll patients in a Phase II trial for its MDM2 inhibitor.

New Products Posted to GenomeWeb: Tempus, Canopy Biosciences, Lonza, More

Mar 3, 2021

Tempus, Texas Oncology Subsidiary Form Data-Focused Precision Oncology Partnership

Feb 25, 2021

Kronos Bio Doses First Patient in CDK9 Inhibitor Trial With Tempus Performing Sequencing

Feb 12, 2021

New Products Posted to GenomeWeb: Tempus, Active Motif, Immudex, Zymo Research, More

Jan 27, 2021

Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance

Jan 13, 2021

Tempus, A2 Biotherapeutics Partner to Develop CDx for Therapy Targeting Loss of Heterozygosity

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Dec 14, 2020

Hummingbird Biosciences, Tempus Partner to ID Cancer Patients for Anti-HER3 Treatment Trial

Dec 10, 2020

Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 24, 2020

Tempus Gets CE Mark for xT Tumor Sequencing Assay

Nov 23, 2020

Novellus, Tempus Partner to Enroll Patients in BRAF Inhibitor Clinical Trial Program

Nov 16, 2020

Tempus, Yale School of Public Health Partner to Update Saliva-Based Coronavirus Test

Nov 2, 2020

Tempus, Janssen R&D Collaborate on Oncology Clinical Trial Matching

Oct 14, 2020

Tempus Enters Infectious Disease Market With Large-Scale COVID-19 Testing, Data Initiative
Premium

Oct 13, 2020

Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform

Oct 2, 2020

Tempus, Alimetrix Molecular Coronavirus Tests Get FDA Emergency Use Authorization

Sep 16, 2020

LabCorp's Covance Joins Tempus TIME Trial Program

Mar 16, 2020

With $100M in New Funding, Tempus Targets Diseases Beyond Cancer
Premium

Mar 13, 2020

Tempus Closes $100M Series G Round

Feb 26, 2020

Congressional Caucus Working to Raise Personalized Medicine Awareness Among Legislators
Premium

Breaking News
The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.